Multiscale Modeling of an 8-Week Combination Regimen of Bemnifosbuvir and Ruzasvir in Patients with Chronic Hepatitis C Virus Infection.

Zitzmann C, Ribeiro RM, Marc A, Zhou XJ, Perelson AS

Open source

DOI
10.1002/cpt.70454
Published
2026 Sep 3
Container
Clinical pharmacology and therapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cpt.70454,
  title = {Multiscale Modeling of an 8-Week Combination Regimen of Bemnifosbuvir and Ruzasvir in Patients with Chronic Hepatitis C Virus Infection.},
  author = {Zitzmann C and Ribeiro RM and Marc A and Zhou XJ and Perelson AS},
  year = {2026},
  journal = {Clinical pharmacology and therapeutics},
  doi = {10.1002/cpt.70454},
  url = {https://doi.org/10.1002/cpt.70454}
}

RIS

TY  - JOUR
TI  - Multiscale Modeling of an 8-Week Combination Regimen of Bemnifosbuvir and Ruzasvir in Patients with Chronic Hepatitis C Virus Infection.
AU  - Zitzmann C
AU  - Ribeiro RM
AU  - Marc A
AU  - Zhou XJ
AU  - Perelson AS
PY  - 2026
JO  - Clinical pharmacology and therapeutics
DO  - 10.1002/cpt.70454
UR  - https://doi.org/10.1002/cpt.70454
ER  - 

APA

C, Z., RM, R., A, M., XJ, Z., & AS, P. (2026). Multiscale Modeling of an 8-Week Combination Regimen of Bemnifosbuvir and Ruzasvir in Patients with Chronic Hepatitis C Virus Infection.. Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.70454

Source records